Adaptive immune cells are necessary for SARS-CoV-2-induced pathology.
Brian ImbiakhaJulie Marie SahlerDavid W BuchholzShahrzad EzzatpourMason C JagerAnnette ChoiI Abrrey MonrealHaewon ByunRichard Ayomide AdelekeJustin LeachGary R WhittakerStephen DewhurstBrian D RuddHector C AguilarAvery AugustPublished in: Science advances (2024)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing global pandemic associated with morbidity and mortality in humans. Although disease severity correlates with immune dysregulation, the cellular mechanisms of inflammation and pathogenesis of COVID-19 remain relatively poorly understood. Here, we used mouse-adapted SARS-CoV-2 strain MA10 to investigate the role of adaptive immune cells in disease. We found that while infected wild-type mice lost ~10% weight by 3 to 4 days postinfection, rag -/- mice lacking B and T lymphocytes did not lose weight. Infected lungs at peak weight loss revealed lower pathology scores, fewer neutrophils, and lower interleukin-6 and tumor necrosis factor-α in rag -/- mice. Mice lacking αβ T cells also had less severe weight loss, but adoptive transfer of T and B cells into rag -/- mice did not significantly change the response. Collectively, these findings suggest that while adaptive immune cells are important for clearing SARS-CoV-2 infection, this comes at the expense of increased inflammation and pathology.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- weight loss
- wild type
- coronavirus disease
- high fat diet induced
- bariatric surgery
- oxidative stress
- body mass index
- rheumatoid arthritis
- adipose tissue
- weight gain
- stem cells
- gastric bypass
- cell therapy
- skeletal muscle
- mesenchymal stem cells
- drug induced
- early onset
- obese patients